Skip to search formSkip to main contentSkip to account menu

CX516

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

1-(quinoxalin-6-ylcarbonyl)piperidine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Clozapine resistance—Augmentation strategies
2010
2010
Positive modulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors reverses sub-chronic PCP-induced deficits in the novel object recognition task in rats
2008
2008
Ampakine CX516 ameliorates functional deficits in AMPA receptors in a hippocampal slice model of protein accumulation
2006
2006
Differential effects of classical neuroleptics and a newer generation antipsychotics on the MK-801 induced behavioural primitivization in mouse
2005
2005
AMPA receptor modulators have different impact on hippocampal pyramidal cells and interneurons
2003
2003
Morphine induction of c-fos expression in the rat forebrain through glutamatergic mechanisms: role of non-n-methyl-d-aspartate receptors
2002
2002
Randomized, double-blind, placebo-controlled international clinical trial of the Ampakine® CX516 in elderly participants with mild cognitive impairment
This progress report briefly describes the rationale and study design for the first cross-national clinical study of a positive… 
2002
2002
Randomized, double-blind, placebo-controlled international clinical trial of the Ampakine CX516 in elderly participants with mild cognitive impairment: a progress report.
This progress report briefly describes the rationale and study design for the first cross-national clinical study of a positive… 
2001
2001
Pharmacological effects of AMPA receptor potentiators LY392098 and LY404187 on rat neuronal AMPA receptors in vitro
2000
2000
Effect of AMPA receptor modulators on hippocampal and cortical function.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)